Sponsors

Imperial College awards grant to Beckman Coulter

Beckman Coulter has been awarded a grant to develop quality assurance and quality control materials to be used to verify the accuracy of a planned point-of-care human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) test for resource-poor countries. The grant was awarded by Imperial College LondonÆs CD4 Initiative, which is funded by the Bill and Melinda Gates Foundation.

Beckman Coulter, along with a group of other companies and organisations, will work with Imperial College to develop a simple CD4 enumeration test for diagnosing and monitoring HIV/AIDS in remote settings where electricity is unreliable, water quality is poor, and healthcare personnel (if available) are poorly trained.

The proposed test will involve a fingerprick sample and a testing mechanism that permits the visual indication of results, similar to that of current pregnancy tests. The new self-contained HIV/AIDS test must be easy-to-use and, more importantly, it must be affordable.

“It is an honour for our parent company to receive this grant and to have the chance to share what we have with those who need it most,” explained Jag Grewal, marketing manager for northern Europe.

Latest Issues

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026

Cell & Gene Therapy 2026

Hinxton Hall Conference Centre, Wellcome Genome Campus, Hinxton, CB10 1RQ
9-10 March, 2026

USCAP 115th Annual Meeting

Henry B. González Convention Center, San Antonio, Texas, USA
21-26 March, 2026